DK499477A - Anvendelse af ergotpeptidalkaloid-praeparat - Google Patents

Anvendelse af ergotpeptidalkaloid-praeparat

Info

Publication number
DK499477A
DK499477A DK499477A DK499477A DK499477A DK 499477 A DK499477 A DK 499477A DK 499477 A DK499477 A DK 499477A DK 499477 A DK499477 A DK 499477A DK 499477 A DK499477 A DK 499477A
Authority
DK
Denmark
Prior art keywords
kaloid
ergotpeptidal
preparation
kaloid preparation
ergotpeptidal kaloid
Prior art date
Application number
DK499477A
Other languages
English (en)
Other versions
DK153440C (da
DK153440B (da
Inventor
M Azria
T Cavanak
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK499477A publication Critical patent/DK499477A/da
Publication of DK153440B publication Critical patent/DK153440B/da
Application granted granted Critical
Publication of DK153440C publication Critical patent/DK153440C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01D—MEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR
    • G01D2207/00—Indexing scheme relating to details of indicating measuring values
    • G01D2207/10—Displays which are primarily used in aircraft or display aircraft-specific information

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK499477A 1976-11-19 1977-11-10 Fremgangsmaade til fremstilling af et nasalt farmaceutisk ergotpeptidalkaloid-praeparat DK153440C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH1457576 1976-11-19
CH1457576 1976-11-19
CH698977 1977-06-07
CH698977 1977-06-07

Publications (3)

Publication Number Publication Date
DK499477A true DK499477A (da) 1978-05-20
DK153440B DK153440B (da) 1988-07-18
DK153440C DK153440C (da) 1989-01-02

Family

ID=25700540

Family Applications (1)

Application Number Title Priority Date Filing Date
DK499477A DK153440C (da) 1976-11-19 1977-11-10 Fremgangsmaade til fremstilling af et nasalt farmaceutisk ergotpeptidalkaloid-praeparat

Country Status (27)

Country Link
US (2) US4462983A (da)
JP (1) JPS5366440A (da)
AT (1) AT368881B (da)
AU (1) AU520754B2 (da)
CA (1) CA1103585A (da)
CS (2) CS228523B2 (da)
CY (1) CY1266A (da)
DE (2) DE2750090A1 (da)
DK (1) DK153440C (da)
ES (1) ES464275A1 (da)
FI (1) FI773376A (da)
FR (1) FR2371454A1 (da)
GB (1) GB1592563A (da)
GR (1) GR65229B (da)
HK (1) HK85984A (da)
HU (1) HU185924B (da)
IE (1) IE46167B1 (da)
IL (1) IL53419A (da)
KE (1) KE3453A (da)
MY (1) MY8400055A (da)
NL (1) NL187892C (da)
NO (1) NO773839L (da)
NZ (1) NZ185711A (da)
PH (1) PH23643A (da)
PT (1) PT67292B (da)
SE (1) SE451944B (da)
SG (1) SG61784G (da)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
US4284648A (en) * 1979-08-03 1981-08-18 The University Of Kentucky Research Foundation Nasal administration of propranolol
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.
FI81258C (fi) * 1982-02-01 1990-10-10 Sandoz Ag Foerfarande foer framstaellning av en farmaceutisk komposition foer nasal administration.
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
GB8413795D0 (en) * 1984-05-30 1984-07-04 Sandoz Ltd Organic compounds
GB8426922D0 (en) * 1984-10-24 1984-11-28 Sandoz Ltd Galenic formulation
GB8501015D0 (en) * 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
FR2628638B1 (fr) * 1985-03-06 1992-12-18 Sandoz Lab Dispositif de pulverisation par voie nasale d'une dose unitaire de medicament en solution
JPS61263918A (ja) * 1985-05-16 1986-11-21 Banyu Pharmaceut Co Ltd 経皮吸収用製剤
JPS63500175A (ja) * 1985-05-22 1988-01-21 リポソ−ム　テクノロジ−，インコ−ポレイテツド リポソ−ム吸入法および吸入システム
CA1291036C (en) * 1986-04-23 1991-10-22 Edwin I. Stoltz Nasal administration of drugs
US4782047A (en) * 1986-05-22 1988-11-01 Syntex Pharmaceuticals International Ltd. Aqueous steroid formulations for nasal administration
US4897256A (en) * 1986-11-25 1990-01-30 Abbott Laboratories LHRH analog formulations
DE3710216A1 (de) * 1987-03-27 1988-10-06 Rentschler Arzneimittel Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen
DE68915203T2 (de) * 1988-03-22 1994-09-22 Fisons Plc, Ipswich, Suffolk Pharmazeutische Mischungen.
US4929640A (en) * 1988-04-04 1990-05-29 George D. McAdory Medicaments intended for combined use in the improvement of lymphocyte function
GB2237510B (en) * 1989-11-04 1993-09-15 Danbiosyst Uk Small particle drug compositions for nasal administration
IT1247472B (it) * 1991-05-31 1994-12-17 Fidia Spa Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
AU659328B2 (en) * 1992-06-12 1995-05-11 Teijin Limited Ultrafine powder for inhalation and production thereof
KR100208979B1 (ko) * 1992-06-12 1999-07-15 야스이 쇼사꾸 기도내 투여용 제제
EP0689438B1 (en) * 1993-03-26 2003-06-04 Franciscus Wilhelmus Henricus Maria Merkus Pharmaceutical compositions for intranasal administration of apomorphine
US5830853A (en) 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
US20010003739A1 (en) * 1993-06-24 2001-06-14 Astrazeneca Ab Systemic administration of a therapeutic preparation
US6632456B1 (en) 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
US6794357B1 (en) 1993-06-24 2004-09-21 Astrazeneca Ab Compositions for inhalation
SE9404468D0 (sv) * 1994-12-22 1994-12-22 Astra Ab Powder formulations
EE9700138A (et) 1994-12-22 1997-12-15 Astra Aktiebolag Aerosoolravimvormid
SK76797A3 (en) * 1994-12-22 1998-02-04 Astra Ab Therapeutic preparation for inhalation containing parathyroid hormone, pth
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5955098A (en) * 1996-04-12 1999-09-21 Flemington Pharmaceutical Corp. Buccal non polar spray or capsule
US7771746B2 (en) * 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
DK1251827T3 (da) * 2000-01-20 2004-09-27 Basilea Pharmaceutica Ag Nasalt administrerbare antifungale cykliske peptidpræparater
US20030008005A1 (en) * 2001-07-05 2003-01-09 R.T. Alamo Ventures, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
GB0208742D0 (en) * 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
GB2405334B (en) * 2002-04-17 2006-02-15 Nektar Therapeutics Uk Ltd Particulate materials
ES2538082T3 (es) 2007-02-11 2015-06-17 Map Pharmaceuticals Inc Método de administración terapéutica de DHE para permitir el rápido alivio de migraña mientras que se minimiza el perfil de efectos secundarios
US20120000941A1 (en) * 2010-06-30 2012-01-05 Inspire Pharmaceuticals, Inc. Medicine dispenser
CN108601916B (zh) 2015-09-10 2021-07-09 英倍尔药业股份有限公司 直列式鼻部递送装置
US20190000753A1 (en) * 2017-07-02 2019-01-03 Dr. Reddy's Laboratories Ltd. Nasal dosage forms of dihydroergotamine
JP7317020B2 (ja) 2018-01-05 2023-07-28 インペル ファーマシューティカルズ インコーポレイテッド 精密嗅覚デバイスによるジヒドロエルゴタミンの鼻腔内送達
CN113423400A (zh) 2018-12-11 2021-09-21 小蜜橘制药公司 用于治疗或预防头痛的组合物、装置和方法
GB2581431A (en) * 2018-12-11 2020-08-19 Satsuma Pharmaceuticals Inc Compositions, devices, and methods for treating or preventing headaches

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1063512A (en) * 1962-11-30 1967-03-30 Benger Lab Ltd Aerosols
GB1175430A (en) * 1966-04-07 1969-12-23 Sandoz Ltd Pharmaceutical Compositions containing Ergot Alkaloids
CH507249A (de) * 1968-05-31 1971-05-15 Sandoz Ag Verfahren zur Herstellung von 2-Brom-a-ergokryptin
CH534683A (de) * 1970-05-26 1973-03-15 Sandoz Ag Verfahren zur Herstellung neuer Mutterkornpeptidalkaloide
CA990287A (en) * 1972-09-26 1976-06-01 Sandoz Patents Limited 13-bromo-lysergic acid compounds
US4076715A (en) * 1972-09-26 1978-02-28 Sandoz Ltd. 13-Bromo lysergic acid compounds
NL7314066A (da) * 1972-10-18 1974-04-22
US3896228A (en) * 1973-03-15 1975-07-22 Sandoz Ltd Method for treating nephrises
US3883655A (en) * 1973-10-11 1975-05-13 Sandoz Ltd Ergocornine or 2-bromo-{60 -ergocyptine in the treatment of parkinsonism
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
EP0119493A1 (en) * 1983-03-16 1984-09-26 American Cyanamid Company Use of copolymers of 2-acrylamido-2-methylpropane sulfonic acid for improving retention and dewatering in the manufacture of paper

Also Published As

Publication number Publication date
US4462983A (en) 1984-07-31
GR65229B (en) 1980-07-30
KE3453A (en) 1984-10-05
SE7712693L (sv) 1978-05-20
HK85984A (en) 1984-11-16
CS228523B2 (en) 1984-05-14
IE46167B1 (en) 1983-03-09
IL53419A (en) 1982-04-30
ES464275A1 (es) 1978-12-16
HU185924B (en) 1985-03-28
AU520754B2 (en) 1982-02-25
PT67292B (fr) 1979-11-12
NZ185711A (en) 1980-04-28
CS228502B2 (en) 1984-04-16
IL53419A0 (en) 1978-01-31
FR2371454B1 (da) 1980-08-22
NL187892C (nl) 1992-02-17
MY8400055A (en) 1984-12-31
SE451944B (sv) 1987-11-09
AU3078377A (en) 1979-05-24
FR2371454A1 (fr) 1978-06-16
IE46167L (en) 1978-05-19
GB1592563A (en) 1981-07-08
NL7712552A (nl) 1978-05-23
US4758423A (en) 1988-07-19
NL187892B (nl) 1991-09-16
FI773376A (fi) 1978-05-20
DK153440C (da) 1989-01-02
CY1266A (en) 1984-11-23
NO773839L (no) 1978-05-22
JPS5366440A (en) 1978-06-13
DK153440B (da) 1988-07-18
DE2802113A1 (de) 1979-07-26
PT67292A (fr) 1977-12-01
CA1103585A (en) 1981-06-23
ATA825477A (de) 1982-04-15
SG61784G (en) 1985-03-15
PH23643A (en) 1989-09-27
AT368881B (de) 1982-11-25
JPS6313965B2 (da) 1988-03-29
DE2750090A1 (de) 1978-06-01

Similar Documents

Publication Publication Date Title
DK499477A (da) Anvendelse af ergotpeptidalkaloid-praeparat
SE7700032L (sv) Framstellning av n-fosfonometylglysin
FR2340298A1 (fr) Preparation de meta-aryloxy-benzaldehydes
DK244577A (da) Fremgangsmade til fremstilling af hydantoinderivater
TR19652A (tr) Gamma-pironlarin hazirlanmasi
DK191877A (da) Derivater af n-phosphonomethylglycin
DK577977A (da) Fremgangsmaade til fremstilling af alfa-l-aspartyl-l-phenylalanin-methyler
DK339677A (da) Fremgangsmade til fremstilling af 2-benzylpyrrolidiner
DK302578A (da) Reduktion af phosphinoxider
BE852557A (fr) Preparation de nouvelles isobutyramides
DK587077A (da) Fremgangsmaade til fremstilling af estere
DK144377A (da) Fremgangsmade til fremstilling af acylcyanider
DK148786C (da) Baererlag bestaaende af vliesstof
DK517176A (da) Fremstilling af ethylchlorthioformiat
DK510977A (da) Hygiejnisk-kosmetisk praeparat
DK216977A (da) Fremgangsmade til fremstilling af imidazobenzoxaziner
DK144277A (da) Fremgangsmade til fremstilling af acylcyanider
DK338780A (da) Phosphorestere af alkylcykloalkyl-5-pyrimidinoler
DK575277A (da) Fremgangsmaade til fremstilling af basisk substituerede 0-propyloximer
DK73277A (da) Fremgangsmaade til fremstilling af sulfonylbenzimidazoler
DK549577A (da) Fremgangsmaade til fremsitlling af oelurt
DK196577A (da) Fremgangsmade til fremstilling af kolecystokinin-pankreozymin-oktapeptidamidsulfatester
DK538977A (da) Fremgangsmaade til fremstilling af 17alfa-hydroxy-21-acetoxy-progesteron
DK106677A (da) Fremgangsmade til fremstilling af 3-nethylencephalosporiner
DK301377A (da) Fremgangsmade til fremstilling af cishexahydrodibenzopyranoner

Legal Events

Date Code Title Description
PUP Patent expired